Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FLORBETAPIR F-18
- B-amyloid as a Marker for GBM Bioimaging
- SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease
- Valacyclovir for Mild Cognitive Impairment
- Entire-body PET Scans for Multiple Sclerosis
- Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18F-florbetapir (AV-45) PET Examination
- Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study
- Initial Investigation of [18F]P16-129 in Alzheimer's Disease Patients and Healthy Volunteers
- MRI and PET Biomarkers for Cognitive Decline in Older Adults
- The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180)
- Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy
- Anti-viral Therapy in Alzheimer's Disease
- Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
- Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain
- The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis
- Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury
- Longitudinal Study of Brain Amyloid imaGing in MEMENTO
- Florbetapir Calibration to the Centiloid Scale
- The Feasibility of Florbetapir Quantitation in Europe
- 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
- Evaluation of Reader Training Processes
- A Study of Gantenerumab in Participants With Mild Alzheimer Disease
- Imaging Non-motor Symptoms of Parkinson's Disease by Novel 18F-DTBZ and Florbetapir F-18 PET
- Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians
- The Feasibility of Florbetapir Quantitation
- Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.
- Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients
- Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline
- Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography
- Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease
- A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
- A Study of Florbetapir (18F) in Japanese Healthy Volunteers
- Effects of Brain Beta-Amyloid on Postoperative Cognition
- Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)
- Evaluation of Physician Training Methods to Read Florbetapir-PET Scans
- A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers
- A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers
- A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers
- A Study of 18F-AV-45 in Healthy Volunteers
- Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans
- Clinical Evaluation of Florbetapir F 18 (18F-AV-45)
- Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07
- Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline
- 18-Month Study of Memory Effects of Curcumin
- Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients
- Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)
- Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain
- A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
Clinical trials list
click for details